Lars Rogge

7PUBLICATIONS
99CO-AUTHORS
Infectious agentsCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 09, 2026
Humans homozygous for rare or common hypomorphic IL23R variants are prone to tuberculosis.

|Feb 24, 2021
Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers.

Ikram Mezghiche, Hanane Yahia-Cherbal, Lars Rogge

|Dec 03, 2020
Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo.

Silvia Menegatti, Vincent Guillemot, Eleonora Latis

|Dec 15, 2019
Metabolomics analysis of human acute graft-versus-host disease reveals changes in host and microbiota-derived metabolites.

David Michonneau, Eleonora Latis, Emmanuel Curis

|Nov 28, 2019
Author Correction: NFAT primes the human RORC locus for RORγt expression in CD4+T cells.

Hanane Yahia-Cherbal, Magda Rybczynska, Domenica Lovecchio

|Oct 18, 2019
NFAT primes the human RORC locus for RORγt expression in CD4+ T cells.

Hanane Yahia-Cherbal, Magda Rybczynska, Domenica Lovecchio

Pageof 2

Frequent Collaborators

3 joint publications

Elisabetta Bianchi

2 joint publications

Domenica Lovecchio

1 joint publications

David Michonneau

1 joint publications

Emmanuel Curis